The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Equillium, Inc(NASDAQ:EQ) 
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. Its primary product candidate is itolizumab, a clinical-stage monoclonal antibody that targets the novel immune ...
Website: http://www.equilliumbio.com
Founded: 2017
Full Time Employees: 26
Sector: Healthcare
Industry: Biotechnology
Equillium Days Payable Outstanding ttm (DPO)
Equillium Days Receivable Outstanding ttm (DSO)
Equillium Op Cashflow Per Share ttm
Equillium Free Cashflow Per Share ttm
Equillium Cash Per Share ttm
Equillium P/S ratio ttm
Equillium (GAAP) P/E ratio ttm
Equillium P/B ratio ttm
No extra charts and metrics for this ticker.